Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.50 |
| ▸ | CPA1 | P15085 | 3/20 | 0.48 |
| ▸ | CPA3 | P15088 | 3/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.48 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL490844 | 0.86 | CYP1A2 (0.61) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL4826192 | 0.86 | CYP1A2 (0.61) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL4316458 | 0.86 | CYP1A2 (0.61) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL10431446 | 0.86 | EPHX1 (0.49) | CYP1A2ALPIPKMPTGS1XIAP | |
| Bromide SCHEMBL1596942 | 0.84 | CYP1A2 (0.59) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL1596941 | 0.84 | CYP1A2 (0.54) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL27964016 | 0.83 | FFAR1 (0.57) | — | |
| SCHEMBL3713994 | 0.83 | ALPI (0.53) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL5246633 | 0.83 | EPHX1 (0.58) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL1173417 | 0.83 | CYP1A2 (0.52) | CYP1A2ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9856229-B2 | Method for producing cyclic carbonate | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2018-01-02 | — | — | US | disclosed |
| US-20160145234-A1 | METHOD FOR PRODUCING CYCLIC CARBONATE | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-05-26 | — | — | US | disclosed |
| EP-3023418-A1 | METHOD FOR MANUFACTURING CYCLIC CARBONATE | National Institute of Advanced Industrial Science and Technology (JP) | 2016-05-25 | — | — | EP | disclosed |
| CN-105452441-A | Serum-free medium containing PDGF for DS cells | SHISEIDO CO LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-105283542-A | Method for producing kidney precursor cells and drug containing kidney precursor cells | NAT UNIV CORP KYOTO UNIV | 2016-01-27 | — | — | CN | disclosed |
| CN-101479376-A | Cell cluster comprising plural kinds of cells derived from soma with ability to form primitive organ-like structure | SHISEIDO CO LTD (JP) | 2009-07-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145234-A1 | METHOD FOR PRODUCING CYCLIC CARBONATE | CA7, CA2, CA4 | CYP1A2 501/4885ALPI 119/4885PKM 2371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.